tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PROK Stock Latest News

Short Report: Sirius XM bears pressing bets into stock rally
The FlyShort Report: Sirius XM bears pressing bets into stock rally
24d ago
ALT
KSS
ProKidney 53.72M share Secondary priced at $2.42
PremiumThe Fly
ProKidney 53.72M share Secondary priced at $2.42
1M ago
PROK
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
PremiumPress Releases
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
1M ago
PROK
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
PremiumPress Releases
ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
1M ago
PROK
ProKidney announces $125M Class A ordinary shares offering
PremiumThe Fly
ProKidney announces $125M Class A ordinary shares offering
1M ago
PROK
ProKidney price target lowered to $6 from $15 at Jefferies
PremiumThe FlyProKidney price target lowered to $6 from $15 at Jefferies
1M ago
PROK
ProKidney Progresses in Kidney Disease Treatment Trials and Regulation
PremiumCompany Announcements
ProKidney Progresses in Kidney Disease Treatment Trials and Regulation
1M ago
8K
PROK
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
PremiumPress Releases
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
1M ago
PROK
ProKidney announces ‘positive’ interim REGEN-007 Phase 2 trial data
PremiumThe Fly
ProKidney announces ‘positive’ interim REGEN-007 Phase 2 trial data
1M ago
PROK
ProKidney Phase 2 Trial Success Sparks Investor Interest
PremiumCompany Announcements
ProKidney Phase 2 Trial Success Sparks Investor Interest
2M ago
8K
PROK
ProKidney price target raised to $4 from $3 at BofA
PremiumThe Fly
ProKidney price target raised to $4 from $3 at BofA
2M ago
NVO
PROK
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
PremiumPress Releases
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
2M ago
PROK
ProKidney sees cash runway into 4Q25
PremiumThe FlyProKidney sees cash runway into 4Q25
2M ago
PROK
ProKidney reports Q1 EPS (16c) vs. (16c) last year
PremiumThe Fly
ProKidney reports Q1 EPS (16c) vs. (16c) last year
2M ago
PROK
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
PremiumPress Releases
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
2M ago
PROK
ProKidney Bolsters Leadership with Expert EVP, Enhances Operations
PremiumCompany Announcements
ProKidney Bolsters Leadership with Expert EVP, Enhances Operations
4M ago
8K
PROK
ProKidney appoints Ulrich Ernst as EVP, technical operations
PremiumThe Fly
ProKidney appoints Ulrich Ernst as EVP, technical operations
4M ago
PROK
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
PremiumPress Releases
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
4M ago
PROK
ProKidney reports FY23 EPS (57c), consensus (65c)
PremiumThe Fly
ProKidney reports FY23 EPS (57c), consensus (65c)
4M ago
PROK
ProKidney assumed with an Equal Weight at Morgan Stanley
PremiumThe FlyProKidney assumed with an Equal Weight at Morgan Stanley
4M ago
PROK
ProKidney Approves New Equity Incentives to Retain Key Staff
PremiumCompany Announcements
ProKidney Approves New Equity Incentives to Retain Key Staff
5M ago
8K
PROK
ProKidney downgraded to Neutral from Buy at BofA
PremiumThe Fly
ProKidney downgraded to Neutral from Buy at BofA
7M ago
PROK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >